A retrospective case-control study for the comparison of 5-year survival rates: the role of adjuvant and neoadjuvant chemotherapy in craniofacial bone sarcoma in adults.

Elena Hofmann,Saskia Preissner,Moritz Hertel,Robert Preissner,Carsten Rendenbach,Anne Flörcken,Max Heiland

Therapeutic advances in medical oncology（2023）

引用 0|浏览8

暂无评分

摘要

The use of neoadjuvant chemotherapy may improve survival rates in patients with surgically treated craniofacial bone sarcomas. Due to the retrospective nature of this study, randomized controlled studies are required to derive treatment recommendations.

查看译文

关键词

adjuvant chemotherapy,chondrosarcoma,craniofacial bone sarcoma,head and neck cancer,neoadjuvant chemotherapy,osteosarcoma,real-world data

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要